SCHEMBL8730263

SCHEMBL8730263

[CH]c1cc(Br)cc(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24617 0.78
Ethylene SCHEMBL27335704 0.70 TDP1 (0.41)
SCHEMBL6745330 0.67
SCHEMBL993217 0.67 APEX1 (0.44)
SCHEMBL8723718 0.67 APEX1 (0.53)
SCHEMBL10040717 0.64 APEX1 (0.41)
Hydrogen Sulfide SCHEMBL11472701 0.64 APEX1 (0.41)
Methoxymethane SCHEMBL27967126 0.64 IDO1 (0.39)
SCHEMBL3181875 0.64
Water SCHEMBL10830901 0.64 APEX1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0609058-B1 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO CO (JP) 1998-12-09 EP disclosed
US-5491167-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY, LIMITED (JP) 1996-02-13 US disclosed
EP-0609058-A2 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1994-08-03 EP disclosed